Money Concepts Capital Corp Acquires 13,875 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Money Concepts Capital Corp increased its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 6.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 245,148 shares of the exchange traded fund’s stock after acquiring an additional 13,875 shares during the quarter. SPDR S&P Biotech ETF makes up 1.6% of Money Concepts Capital Corp’s investment portfolio, making the stock its 12th largest position. Money Concepts Capital Corp owned approximately 0.32% of SPDR S&P Biotech ETF worth $22,078,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also recently made changes to their positions in XBI. Avior Wealth Management LLC raised its holdings in shares of SPDR S&P Biotech ETF by 393.6% during the fourth quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock valued at $35,000 after acquiring an additional 307 shares in the last quarter. Tidemark LLC lifted its position in shares of SPDR S&P Biotech ETF by 101.5% in the 3rd quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock worth $39,000 after purchasing an additional 199 shares during the period. Quintet Private Bank Europe S.A. bought a new stake in shares of SPDR S&P Biotech ETF during the 3rd quarter valued at about $40,000. ORG Wealth Partners LLC purchased a new position in shares of SPDR S&P Biotech ETF during the third quarter valued at about $44,000. Finally, Howe & Rusling Inc. purchased a new stake in SPDR S&P Biotech ETF in the third quarter worth about $49,000.

SPDR S&P Biotech ETF Stock Up 1.3 %

XBI opened at $92.57 on Wednesday. SPDR S&P Biotech ETF has a 52 week low of $81.14 and a 52 week high of $105.47. The stock has a market cap of $7.06 billion, a PE ratio of 11.47 and a beta of 1.11. The business has a 50 day moving average of $92.99 and a 200-day moving average of $96.59.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.